Literature DB >> 2023216

IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus.

C Siegert1, M Daha, M L Westedt, E van der Voort, F Breedveld.   

Abstract

We investigated the association between serum titers of IgG antibodies against C1q (C1qAb) and clinical and laboratory variables of disease activity in systemic lupus erythematosus (SLE). C1qAb were measured by ELISA in serum samples of 88 patients. Thirty patients (34%) had increased C1qAb titers. No correlation between C1qAb titers and a score for general disease activity was found. However, significant positive correlations were found between C1qAb titers and the presence of several clinical and laboratory variables of disease activity. These included nephritis, dermatitis, hypocomplementemia, antibodies against dsDNA, and circulating immune complexes. A negative correlation was found with neurological disease manifestations. The correlations between C1qAb titers and clinical features indicate that the pathogenetic role for C1qAb in certain disease manifestations of SLE deserves further study.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2023216

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  51 in total

Review 1.  The use of laboratory tests in the diagnosis of SLE.

Authors:  W Egner
Journal:  J Clin Pathol       Date:  2000-06       Impact factor: 3.411

Review 2.  Autoantibodies against C1q: view on clinical relevance and pathogenic role.

Authors:  C E Siegert; M D Kazatchkine; A Sjöholm; R Würzner; M Loos; M R Daha
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

3.  Antibodies against C1q in anti-glomerular basement membrane nephritis.

Authors:  I E Coremans; M R Daha; E A van der Voort; Y Muizert; C Halma; F C Breedveld
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

4.  Anti-C1q antibodies in hepatitis C virus infection.

Authors:  D Saadoun; S Sadallah; M Trendelenburg; N Limal; D Sene; J C Piette; J A Schifferli; P Cacoub
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

Review 5.  Antibodies against C1q in patients with systemic lupus erythematosus.

Authors:  Marten Trendelenburg
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

6.  Anti-C1q receptor/calreticulin autoantibodies in patients with systemic lupus erythematosus (SLE).

Authors:  R H van den Berg; C E Siegert; M C Faber-Krol; T W Huizinga; L A van Es; M R Daha
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

7.  Anti-C1q antibodies are associated with systemic lupus erythematosus disease activity and lupus nephritis in northeast of China.

Authors:  Cai-Qin Zhang; Lei Ren; Fei Gao; Feng-Yun Mu; Yan-Qiu You; Yan-Hong Liu
Journal:  Clin Rheumatol       Date:  2011-02-23       Impact factor: 2.980

8.  Anti-chromatin and anti-histone antibodies in Egyptian patients with systemic lupus erythematosus.

Authors:  Adel A Shabana; Atef E El-Ghawet; Shereen A Machaly; Ekbal M Abu Hashim; Basma A El-Kady; Reham Shaat
Journal:  Clin Rheumatol       Date:  2009-03-14       Impact factor: 2.980

9.  Anti-mannose binding lectin antibodies in sera of Japanese patients with systemic lupus erythematosus.

Authors:  R Takahashi; A Tsutsumi; K Ohtani; D Goto; I Matsumoto; S Ito; N Wakamiya; T Sumida
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

10.  Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus.

Authors:  Olivier C Meyer; Pascale Nicaise-Roland; Nolwenn Cadoudal; Sabine Grootenboer-Mignot; Elisabeth Palazzo; Gilles Hayem; Philippe Dieudé; Sylvie Chollet-Martin
Journal:  Arthritis Res Ther       Date:  2009-06-10       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.